Bristol Myers - Celgene CVRPreferred / convertible
13F holders, Q2 2024 (June 30)18holders −2
0new positions
2sold out
1famous investor
$8.30avg. 13F price*
At the end of Q2 2024, 18 institutions reported holding Bristol Myers - Celgene CVR in their 13F filings, down 2 from Q1 2024. 0 opened new positions and 2 sold out. The largest holders were FourWorld Capital Management LLC ($4.2M), Susquehanna International Group, LLP ($5K) and Transcend Capital Advisors, LLC ($5K). One famous investor held it Ken Griffin ( of Citadel Advisors's portfolio).
- Company
- Bristol Myers - Celgene CVR
- CUSIP
- 110122140
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024 → Q2 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 2 | $2K |
All 13F filers, Q1 2024 → Q2 2024: 44,217 shares bought and 30,628 shares sold, net +13,589 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 18 holders
| FourWorld Capital Management LLC | — | No change | 100,000 | $4.2M |
| Susquehanna International Group, LLP | — | Add +56.5% | 122,175 | $5K |
| Transcend Capital Advisors, LLC | — | No change | 117,775 | $5K |
| DAVENPORT & Co LLC | — | No change | 83,970 | $3K |
| Citadel Advisors | — | Reduce -0.3% | 37,904 | $2K |
| Fifth Third Bancorp | — | No change | 20,000 | $820 |
| Private Advisor Group, LLC | — | No change | 15,000 | $615 |
| Bank of America Corp. | — | No change | 1,838 | $75 |
| Northwestern Mutual Wealth Management Co. | — | Add +40.9% | 341 | $14 |
| Rothschild Investment LLC | — | No change | 166 | $7 |
| Morgan Stanley | — | No change | 164 | $7 |
| International Assets Investment Management, LLC | — | No change | 175 | $7 |
| Oakworth Capital, Inc. | — | No change | 125 | $5 |
| JPMorgan Chase & Co. | — | No change | 23 | $1 |
| Wells Fargo & Company | — | No change | 28 | $1 |
| UBS Group AG | — | Add +3.3% | 31 | $1 |
| Atlantic Edge Private Wealth Management, LLC | — | No change | 16 | $1 |
| Royal Bank of Canada | — | No change | 2,475 | $0 |
"% of holder's portfolio" is BRISTOL MYERS - CELGENE CVR's weight in each manager's 13F, not the share of Bristol Myers - Celgene CVR the manager owns.